Determination of lamotrigine in human plasma by high-performance liquid chromatography

被引:56
作者
Angelis-Stoforidis, P
Morgan, DJ
O'Brien, TJ
Vajda, FJE
机构
[1] St Vincents Hosp, Australian Ctr Clin Neuropharmacol, Fitzroy, Vic 3065, Australia
[2] Victorian Coll Pharm, Dept Pharmaceut, Melbourne, Vic, Australia
来源
JOURNAL OF CHROMATOGRAPHY B | 1999年 / 727卷 / 1-2期
关键词
lamotrigine;
D O I
10.1016/S0378-4347(99)00043-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The method involves precipitation of plasma proteins with acetonitrile and analysis of the supernatant by high-performance liquid chromatography using a 5 mu m Zorbax C8 column. Quantitation was performed by measurement of the UV absorbance at a wavelength of 306 nm. The method was linear in the range of 1-20 mu g/ml, with a mean coefficient of determination (r(2) = 0.998). The limit of detection was 0.6 mu g/ml and the lower limit of quantitation was 1 mu g/ml using 200 mu l of plasma. Within- and between-day accuracy and precision were below 6% at all analysed concentrations except at the limit of quantitation. No interfering peaks were found by commonly monitored antiepileptic drugs. Recovery was found to be greater than or equal to 99%. Satisfactory performance was obtained in the evaluation of epileptic patient samples, whose results of plasma concentration measurements are briefly discussed. We conclude that this is a reliable method for the routine monitoring of lamotrigine concentration in plasma in the clinical setting. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 21 条
[1]  
BOUTAGY J, 1995, THER DRUG MONIT, V17, P410
[2]   LAMOTRIGINE [J].
BRODIE, MJ .
LANCET, 1992, 339 (8806) :1397-1400
[3]   PERFORMANCE ANALYSIS OF A REVERSED-PHASE LIQUID-CHROMATOGRAPHIC ASSAY OF LAMOTRIGINE IN PLASMA USING SOLVENT-DEMIXING EXTRACTION [J].
COCIGLIO, M ;
ALRIC, R ;
BOUVIER, O .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 572 (1-2) :269-276
[4]   LAMOTRIGINE, A NEW ANTICONVULSANT - PHARMACOKINETICS IN NORMAL HUMANS [J].
COHEN, AF ;
LAND, GS ;
BREIMER, DD ;
YUEN, WC ;
WINTON, C ;
PECK, AW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 42 (05) :535-541
[5]   Antiepileptic drug cellular mechanisms of action: Where does lamotrigine fit in? [J].
Coulter, DA .
JOURNAL OF CHILD NEUROLOGY, 1997, 12 :S2-S9
[6]  
EDELBROEK PM, 1996, EPILEPSIA S4, V37, P64
[7]   A LIQUID-CHROMATOGRAPHIC ASSAY USING A HIGH-SPEED COLUMN FOR THE DETERMINATION OF LAMOTRIGINE, A NEW ANTIEPILEPTIC DRUG, IN HUMAN PLASMA [J].
FAZIO, A ;
ARTESI, C ;
RUSSO, M ;
TRIO, R ;
OTERI, G ;
PISANI, F .
THERAPEUTIC DRUG MONITORING, 1992, 14 (06) :509-512
[8]   LAMOTRIGINE ANALYSIS IN SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
FRASER, AD ;
MACNEIL, W ;
ISNER, AF ;
CAMFIELD, PR .
THERAPEUTIC DRUG MONITORING, 1995, 17 (02) :174-178
[9]   ROUTINE THERAPEUTIC MONITORING OF LAMOTRIGINE IN EPILEPTIC PATIENTS USING A SIMPLE AND RAPID HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC TECHNIQUE [J].
GEORGE, S ;
WOOD, AJ ;
BRAITHWAITE, RA .
ANNALS OF CLINICAL BIOCHEMISTRY, 1995, 32 :584-588
[10]   A rapid cost-effective high-performance liquid chromatographic (HPLC) assay of serum lamotrigine after liquid-liquid extraction and using HPLC conditions routinely used for analysis of barbiturates [J].
Hart, AP ;
MazarrProo, S ;
Blackwell, W ;
Dasgupta, A .
THERAPEUTIC DRUG MONITORING, 1997, 19 (04) :431-435